Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER

被引：0
|
作者：
Mitsuyoshi Takahara
Tomoya Mita
Naoto Katakami
Fumitaka Wada
Naru Morita
Yoko Kidani
Toshitaka Yajima
Iichiro Shimomura
Hirotaka Watada
机构：
[1] Osaka University,Department of Diabetes Care Medicine, Graduate School of Medicine
[2] Juntendo University Graduate School of Medicine,Department of Metabolism and Endocrinology
[3] Osaka University,Department of Metabolic Medicine, Graduate School of Medicine
[4] AstraZeneca K.K.,Medical Affairs
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Antidiabetic drugs; Diabetes complications; Glycaemic control; Second-line treatment; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：251 / 264
页数：13
相关论文
共 50 条
  • [1] Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER
    Takahara, Mitsuyoshi
    Mita, Tomoya
    Katakami, Naoto
    Wada, Fumitaka
    Morita, Naru
    Kidani, Yoko
    Yajima, Toshitaka
    Shimomura, Iichiro
    Watada, Hirotaka
    DIABETES THERAPY, 2022, 13 (02) : 251 - 264
  • [2] Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study
    Naoto Katakami
    Tomoya Mita
    Mitsuyoshi Takahara
    Toshitaka Yajima
    Fumitaka Wada
    Masaru Kawashima
    Iichiro Shimomura
    Hirotaka Watada
    Diabetes Therapy, 2020, 11 : 1563 - 1578
  • [3] Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study
    Katakami, Naoto
    Mita, Tomoya
    Takahara, Mitsuyoshi
    Yajima, Toshitaka
    Wada, Fumitaka
    Kawashima, Masaru
    Shimomura, Iichiro
    Watada, Hirotaka
    DIABETES THERAPY, 2020, 11 (07) : 1563 - 1578
  • [4] Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme
    Khunti, Kamlesh
    Chen, Hungta
    Cid-Ruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Ji, Linong
    Kosiborod, Mikhail
    Pocock, Stuart
    Shestakova, Marina, V
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Nicolucci, Antonio
    DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 66 - 78
  • [5] Glycaemic control in 14,005 patients with type 2 diabetes initiating second-line therapy in 36 countries: the DISCOVER study
    Ji, L.
    Nicolucci, A.
    Arya, N.
    Cid-Ruzafa, J.
    Fenici, P.
    Gomes, M. B.
    Hammar, N.
    Kosiborod, M.
    Pocock, S.
    Shestakova, M. V.
    Watada, H.
    Shimomura, I.
    Tang, F.
    Khunti, K.
    DIABETOLOGIA, 2017, 60 : S140 - S141
  • [6] Glycaemic Control in 14,005 Patients with Type 2 Diabetes Initiating Second-Line Therapy in 36 Countries: The DISCOVER Study
    Khunti, Kamlesh
    Arya, Nikita
    Cid-Ruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Ji, Linong
    Kamal, Samer
    Kosiborod, Mikhail
    Pocock, Stuart
    Shestakova, Marina V.
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Nicolucci, Antonio
    DIABETES, 2017, 66 : A447 - A447
  • [7] Treatment patterns and associated factors in 13,379 patients with type 2 diabetes initiating a second-line therapy: the DISCOVER study
    Nicolucci, A.
    Arya, N.
    Charbonnel, B.
    Cid-Ruzafa, J.
    Fenici, P.
    Gomes, M. B.
    Hammar, N.
    Khunti, K.
    Kosiborod, M.
    Shestakova, M. V.
    Watada, H.
    Shimomura, I.
    Tang, F.
    Pocock, S.
    DIABETOLOGIA, 2017, 60 : S301 - S302
  • [8] Treatment Patterns and Associated Factors in 13,379 Patients with Type 2 Diabetes Initiating a Second-Line Therapy: The DISCOVER Study
    Nicolucci, Antonio
    Arya, Nikita
    Charbonnel, Bernard
    Cidruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Kamal, Samer
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Shestakova, Marina V.
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Pocock, Stuart
    DIABETES, 2017, 66 : A326 - A326
  • [9] Vascular events in patients with type 2 diabetes in the year following initiation of second-line therapy: the DISCOVER study
    Surmont, F.
    Chen, H.
    Cid-Ruzafa, J.
    Fenici, P.
    Gomes, M. B.
    Khunti, K.
    Pocock, S.
    Rathmann, W.
    Shestakova, M. V.
    Shimomura, I.
    Tang, F.
    Watada, H.
    Ji, L.
    Hammar, N.
    Kosiborod, M.
    DIABETOLOGIA, 2018, 61 : S562 - S562
  • [10] Global Prevalence of Type 2 Diabetes Complications in 14,391 Patients Initiating Second-Line Therapy: The DISCOVER Study
    Kosiborod, Mikhail
    Arya, Nikita
    Cid-Ruzafa, Javier
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Kamal, Samer
    Nicolucci, Antonio
    Pocock, Stuart
    Rathmann, Wolfgang
    Shestakova, Marina V.
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Khunti, Kamlesh
    DIABETES, 2017, 66 : A80 - A80
12345